Aakaar Medical Technologies reported FY26 revenue of INR 67 Cr (up 8.6%) and PAT of INR 6.63 Cr (up 10%). The company is shifting towards an asset-light DODO clinic model via its Xelix platform.
KRM Ayurveda crossed ₹100 Cr revenue in FY26, reporting 32.84% growth. Strategy focuses on integrated healthcare through hospital expansion, specialty Ayurvedic care, and digital telehealth.
CARE Ratings delivered strong FY26 performance with consolidated revenue up 18% and PAT up 24%. Strategy focuses on scaling global rating entities and non-rating AI-driven analytics.
Esconet reported FY26 consolidated revenue of ₹357.84 Cr, up 53.4% YoY. Strategy focuses on 'The Sovereign Stack' integrating hardware, cloud, and cybersecurity.
Management reported strong Q4 growth but faces significant raw material headwinds and global volatility. Profits were hit by a major ₹48.8 Cr impairment of their German subsidiary, MFT, masking underlying operating resilience.
Management update on the non-renewal of Henkel brand licenses (Pril and Fa) effective June 1, 2026. Company is shifting focus to scaling 'Exo' Dishwash Liquid and has initiated arbitration in Singapore.
JD Cables reports strong FY26 performance with Revenue at ₹364.59 Cr and PAT at ₹31.72 Cr. Strategy focuses on product expansion and strategic diversification into Infrastructure/Power EPC projects.
Apex Ecotech reports record FY26 performance with revenue growing 109.5% YoY to ₹148.65 Cr and PAT rising 98.8% to ₹17.02 Cr, driven by execution in water treatment.
Vedanta is executing a massive demerger into five focused entities to unlock shareholder value. Management is pivotting to high-growth, vertically integrated structures with a heavy reliance on aluminum and zinc as primary EBITDA drivers.
Vedanta reports highest-ever 3Q EBITDA of ₹15,171cr (+34% YoY) and 41% margin. Strategy focuses on cost leadership in Aluminum/Zinc and massive capacity expansion across 5 segments by FY27/FY28.
Balrampur Chini Mills reported FY26 revenue of ₹6,271cr with EBITDA of ₹741cr. The company is diversifying into Bioplastics (PLA) with a 250 TPD plant under implementation to create new revenue streams.
Gravita reported steady Q3FY26 performance with 32% YoY PAT growth. Focus remains on scaling to 7 lakh MTPA capacity by FY2028 and diversifying into lithium-ion, paper, and steel recycling.
Gravita reported consistent Q3FY26 performance with 32% YoY PAT growth. Management highlighted capacity expansion delays but remains committed to Vision 2029 diversification into lithium-ion, steel, and paper.
RBM Infracon reported FY26 revenue of ₹492.22cr (up 53%) and PAT of ₹45.28cr (up 54%). Strategy focuses on EPC, O&M, and a major strategic entry into the semiconductor space.
RHI Magnesita India achieved record FY26 revenue of ₹4,01,995 Lakhs (up 9%), though Adjusted EBITDA fell 6% to ₹47,689 Lakhs due to input cost pressures and rupee devaluation.
IndiQube delivered a record FY26 with 37% revenue growth and 145% PAT surge (IGAAP), though Ind AS 116 accounting adjustments resulted in a reported net loss.
Gurunanak Agriculture India Ltd reported 24% EBITDA margins for FY26, driven by a shift toward high-margin combined harvesters. The company is pivoting from threshers to harvesters, targeting a Make-in-India competitive advantage over Chinese imports.
HOEC reported challenging FY26 results with negative growth due to production declines and reversed sales to HPCL. Management remains focused on high-potential 2P reserves of 60 MMBOE and infrastructure debottlenecking.
Indian Phosphate Limited (IPHL) reported strong FY26 results with consolidated revenue crossing ₹1,072 Cr, driven by its chemicals (LABSA) and phosphatic fertilizers (Ankur SSP) business.
Health X Platform (formerly SastaSundar) reported FY26 revenue of ₹1283cr (+18% YoY) and narrowed EBITDA loss to ₹65cr. Strategy focuses on B2B expansion via Retailer Shakti and new JITO private labels.